Intravascular haemolysis and renal failure caused by intermittent rifampicin treatment.
作者信息
Criel A, Verwilghen R L
出版信息
Blut. 1980 Feb;40(2):147-50. doi: 10.1007/BF01013697.
PMID:7353082
Abstract
Rifampicin is a widely used anti-tuberculous drug. Administered daily, only minimal side-effects occur. With intermittent therapy and, as happened in the present case, when the drug is administered after an interruption of treatment, severe adverse reactions [5] (thrombocytopenia, renal failure, and haemolysis) may occur.
摘要
Zotero 插件